Related Experiment Video

Updated: Aug 11, 2026

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
04:27

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Published on: May 4, 2020

High-frequency oscillation and paralysis stabilize surfactant protein-B--deficient infants

E L King1, G D Shackelford, A Hamvas

  • 1Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine and St. Louis Children's Hospital, St. Louis, MO, USA.

Journal of Perinatology : Official Journal of the California Perinatal Association
|March 16, 2002
PubMed

Insights

High-frequency ventilation with neuromuscular blockade significantly improves oxygenation and lung imaging in infants with surfactant protein-B deficiency. This approach is recommended for managing these critical patients.

Area of Science:

  • Pediatric Pulmonology
  • Critical Care Medicine
  • Neonatology

Background:

  • Surfactant protein-B (SP-B) deficiency is a rare, severe genetic disorder leading to respiratory failure in infants.
  • Conventional ventilation strategies often prove insufficient for managing SP-B deficiency, necessitating advanced respiratory support.
  • Lung transplantation is a potential treatment, but infants require optimized care while awaiting the procedure.

Purpose of the Study:

  • To compare the efficacy of high-frequency oscillatory ventilation (HFOV) with and without neuromuscular blockade (NMB) in improving oxygenation and chest radiographic appearance in SP-B deficient infants.
  • To evaluate the impact of NMB on respiratory support in this specific patient population.

Main Methods:

  • Retrospective review of medical records and chest radiographs from five infants with SP-B deficiency undergoing HFOV.
  • Analysis of changes in fraction of inspired oxygen (FiO2) and radiographic scores in relation to NMB status.
  • Correlation analysis between FiO2 changes and radiographic score improvements.

Main Results:

  • HFOV without NMB led to a significant increase in FiO2 (0.20, p=0.02), but chest radiographs deteriorated (p=0.01).
  • HFOV with NMB resulted in a decrease in FiO2 (-0.14, p=0.05) and a significant improvement in chest radiographic appearance (p=0.03).
  • A strong positive correlation was observed between FiO2 changes and improvements in radiographic scores (r=0.7, p<0.001).

Conclusions:

  • High-frequency oscillatory ventilation combined with neuromuscular blockade effectively optimizes oxygenation and improves lung aeration in infants with SP-B deficiency.
  • This ventilatory strategy is a valuable consideration for managing SP-B deficient infants awaiting diagnosis or lung transplantation.
Abstract

More Related Videos

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome (ARDS)

Published on: April 7, 2021

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...